Importantly, these regions were more enriched in H3K27me3 in MM patient samples than in NPCs, underscoring the potential clinical relevance of their reactivation through dual EZH2 and DNMTs inhibition. This evidence concerns the gene EZH2 and Miyoshi myopathy.